Apoptosis, cancer and cancer therapy

Surgical Oncology

Volumn 6, Issue 3, 1997, Pages 133-142

  Bold, R J ^a   Termuhlen, P M ^a   McConkey, D J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; bcl 2; Chemotherapy; Metastasis; Radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; PACLITAXEL; TOPOTECAN;

APOPTOSIS; CELL DEATH; GENE THERAPY; HUMAN; MALIGNANT TRANSFORMATION; METASTASIS; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE;

EID: 0031424574     PISSN: 09607404     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-7404(97)00015-7     Document Type: Review

References (69)

1. C.O.C. Bellamy R.D.G. Malcomson D.J. Harrison A.H. Wyllie Cell death in health and disease: the biology and regulation of apoptosis Seminars in Cancer and Biology 6 1995 3 16
2. S.W. Lowe The role of p53 in apoptosis M Sluyser Apoptosis in Normal Development and Cancer 1996 Taylor & Francis 97 126
3. J.F.R. Kerr A.H. Wyllie A.R. Currie Apoptosis: A basic biological phenomenon with wide-ranging implications in tissue kinetics British Journal of Cancer 26 1972 239 257
4. A.H. Wyllie J.F.R. Kerr A.R. Currie Cell death: the significance of apoptosis International Review of Cytology 68 1980 251 305
5. C.B. Thompson Apoptosis in the pathogenesis and treatment of disease Science 267 1995 1456 1462
6. S. Sen D'Incalci Apoptosis: biochemical events and relevance to cancer chemotherapy FEBS Letters 307 1992 122 127
7. T.J. McDonnell R.E. Meyn L.E. Robertson Implications of apoptotic cell death regulation in cancer therapy Seminars in Cancer and Biology 6 1995 53 60
8. E. White Life, death and the pursuit of apoptosis Genes and Development 10 1996 1 15
9. S. Rowan D.E. Fisher Mechanisms of apoptotic cell death Leukemia 11 1997 457 465
10. J.F.R. Kerr C.M. Winterford B.V. Harmon Apoptosis: its significance in cancer and cancer therapy Cancer 73 1994 2013 2226
11. D.S. Martin G.K. Schwartz Chemotherapeutically induced DNA damage, ATP depletion, and the apoptotic biochemical cascade Oncology Research 9 1997 1 5
12. P. Naik J. Karrim D. Hanahan The rise and fall of apoptosis during multistage tumorigenesis: down-modulation contributes to tumor progression from angiogenic progenitors Genes and Development 10 1996 2105 2116
13. J.C. Reed T. Miyashita S. Takayama H.-G. Wang T. Sato C. Aime-Sempe S. Bodrug S. Kitada M. Hanada BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy Journal of Cellular Biology 60 1996 23 32
14. R.E. Meyn L.C. Stephen L. Milas Programmed cell death and radioresistance Cancer Metastasis Reviews 15 1996 119 131
15. Y. Hannun A. Apoptosis and the dilemma of cancer chemotherapy Blood 89 1997 1845 1853
16. J.C. Reed Bcl-2 family proteins: regulators of chemoresistance in cancer Toxicology Letters 82–83 1995 155 158
17. J.C. Reed Bcl-2: Prevention of apoptosis as a mechanism of drug resistance Hematology and Oncology Clinics of North America 9 1995 451 473
18. J.C. Reed Regulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistance Current Opinions in Oncology 7 1995 541 546
19. J.A. Hickman Apoptosis and chemotherapy resistance European Journal of Cancer 32A 1996 921 926
20. D.J. McConkey S. Orrenius Signal transduction pathways in apoptosis Stem Cells 14 1996 619 631
21. McConkey D. J. and Orrenius S. Biochemical and molecular mechanisms in apoptosis (programmed cell death). Frontiers in Biology; Encyclopedia Italiana . (in press).
22. Y. Tsujimoto C.M. Croce Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma Proceedings of the National Academy of Sciences, U.S.A. 83 1986 5214 5218
23. Z.N. Oltval S.J. Korsmeyer Checkpoints of dueling dimers foil death wishes Cell 79 1994 189 192
24. J.C. Reed Bcl-2 and the regulation of programmed cell death Journal of Cellular Biology 124 1994 1 6
25. M. Oren Relationship of p53 to the control of apoptotic cell death Seminars in Cancer and Biology 5 1994 221 227
26. D. Ronen D. Schwartz Y. Teitz N. Goldfinger V. Rotter Induction of HL-60 cells to undergo apoptosis is determined by high levels of wild-type p53 protein whereas differentiation of the cells is mediated by lower p53 levels Cell Growth Differentiation 7 1996 21 30
27. F.A. Sinicrope S.B. Ruan K.R. Cleary L.C. Stephens J.J. Lee B. Levin bcl-2 and p53 oncoprotein expression during colorectal tumorigenesis Cancer Research 55 1995 237 241
28. J.A. Eastham A.M.F. Stapleton A.E. Gousse T.L. Timme G. Yang K.M. Slawin T.M. Wheeler P.T. Scardino T.C. Thompson Association of p53 mutations with metastatic prostate cancer Clinical Cancer Research 1 1995 1111 1118
29. T. Strobel L. Swanson S. Korsmeyer S. Cannistra BAX enhances paclitaxel-induced apoptosis through a p53-independent pathway Proc. Natl. Acad. Sci. USA 93 1996 14094 14099
30. Y.-F. Chang L.L. Li C.-W. Wu T.-Y. Liu W.-Y. Lui F.-K. Pueng C.-W. Chi Paclitaxel-induced apoptosis in human gastric carcinoma cell lines Cancer 77 1996 14 18
31. L protein content in HT-29 cells Oncogene 13 1996 2631 2637
32. T. Miyashita J.C. Reed Tumor suppressor p53 is a direct transcriptional activator of the human bax gene Cell 80 1995 293 299
33. S.-W. Chiou L. Rao E. White Bcl-2 blocks p53-dependent apoptosis Molecular and Cellular Biology 14 1994 2556 2563
34. C. Friesen I. Herr P.H. Krammer K.-M. Debatin Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells Nature Medicine 2 1996 574 577
35. M. Muller S. Strand H. Hug E.-M. Heinemann H. Walczak W.J. Hofmann W. Stremmel P.H. Krammer P.R. Galle Drug-induced apoptosis in hepatoma cells in mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53 Journal of Clinical Investigations 99 1977 403 413
36. L.J. Ko C. Prives p53: puzzle and paradigm Genes and Development 10 1996 1054 1072
37. D.J. McConkey J. Chandra S. Wright W. Plunkett T.J. McDonnell J.C. Reed M. Keating Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX Journal of Immunology 156 1996 2624 2630
38. N. Rampino H. Yamamoto Y. Ionov Y. Li H. Sawai J.C. Reed M. Perucho Somatic frameshift mutations in the bax gene are associated in colon cancers of the microsatellite mutator phenotype Science 275 1997 967 969
39. S.C. Dixon B.J. Soriano R.M. Lush M.M. Borner W.D. Figg Apoptosis: its role in the development of malignancies and its potential as a novel therapeutic target Annals of Pharmacotherapeutics 31 1997 76 82
40. Meterissian S. H. Apoptosis: its role in the progression of and chemotherapy for carcinoma. Journal of the American College of Surgeons 7 199, 184 , 658–666.
41. C.W. Dewey C.C. Ling R.E. Meyn Radiation-induced apoptosis: relevance to radiotherapy International Journal of Radiation Oncology and Biological Physics 33 1995 781 796
42. T. Strobel L. Swanson S. Korsmeyer S. Cannistra Radiation-induced apoptosis is not enhanced by expression of either p53 or BAX in SW626 ovarian cancer cells Oncogene 14 1997 2753 2758
43. R.E. Meyn Apoptosis and response to radiation: implications for radiation therapy Oncology 11 1977 349 356
44. C. Sakakura E.A. Sweeney T. Shirahama Y. Igarashi S.-I. Hakomori H. Nakatani H. Tsujimoto T. Imanishi M. Ohgaki T. Ohyama J. Yamazaki A. Hagiwara T. Yamuguchi K. Sawai T. Takahashi Overexpression of bax sensitizes human breast cancer MCF-7 cells to radiation-induced apoptosis International Journal of Cancer 67 1996 101 105
45. 125I-5-iodo-2′-deoxyuridine Journal of the National Cancer Institute 46 1970 773 783
46. A. Takaoka M. Adachi H. Okuda S. Sato A. Yawata Y. Hinoda S. Takayama J.C. Reed K. Imai Anti-cell death activity promotes pulmonary metastasis of melanoma cells Oncogene 14 1997 2971 2977
47. T.J. McDonnell P. Troncoso S.M. Brisbay C. Logothetis L.W. Chung J.T. Hsieh S.M. Tu M.L. Campbell Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer Cancer Research 52 1992 6940 6944
48. F.A. Sinicrope D.B. Evans S.D. Leach K.R. Cleary C.J. Fenoglio J.J. Lee Abbruzzese bcl-2 and p53 expression in resectable pancreatic adenocarcinomas: association with clinical outcome Clinical Cancer Research 2 1996 2015 2022
49. P.M. Termuhlen D.J. McConkey Increased sensitivity to apoptosis in human colon cancer cell lines associated with increased metastatic potential Proceedings of the American Association of Cancer Research 1997 Abstract 913
50. C. Doglioni A.P. Dei Tos L. Laurino S. Chiarelli M. Barbareschi G. Viale The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status Virchows Archiv A Pathology, Anatomy and Histology 424 1994 47 51
51. D.J. McConkey G. Greene C.A. Pettaway Apoptosis resistance increase with metastatic potential in cell of the human LNCaP prostate carcinoma line Cancer Research 56 1996 5594 5599
52. S. Huang M. Luca M. Gutman D.J. McConkey K.E. Langley S.D. Lyman M. Bar-Eli Enforced c-KIT expression renders highly metastatic human melanoma cells susceptible to stem cell factor-induced apoptosis and inhibits their tumorigenic and metastatic potential Oncogene 13 1996 2339 2347
53. K. Xie S. Huang Z. Dong S.-H. Juang M. Gutman Q.-W. Xie C. Nathan I.J. Fidler Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells Journal of Experimental Medicine 181 1995 1333 1343
54. th Cancer Symposium of the Society of Surgical Oncology 1995
55. M. Krajewska S.F. Moss S. Krajewska S. Ki P.R. Holt J.C. Reed Elevated expression of bcl-x and reduced bak in primary colorectal adenocarcinomas Cancer Res 56 1996 2422 2427
56. C. Murray Tumour dormancy: not so sleepy after all Nature Medicine 1 1995 117 118
57. L. Holmgren M.D. O'Reilly J. Folkman Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression Nature Medicine 1 1995 149 153
58. L. Holmgren Antiangiogenesis restricted tumor dormancy Cancer Metastasis Reviews 15 1996 241 245
59. K. Takayama K. Ogata Y. Nakanishi J. Yatsunami M. Kawasaki N. Hara Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer Cancer Journal of Science America 2 1996 212 216
60. C. Ceccarelli D. Santini P. Chieco M. Taffurelli D. Marrano A.M. Mancini Multiple expression patterns of biopathological markers in primary invasive breast carcinoma: a useful tool for elucidating its biological behavior Annals of Oncology 6 1995 275 282
61. C. Caserini G. Pratesi M. Tortoreto B. Bedogne N. Carenini R. Supino P. Perego S.C. Righetti F. Zunino Apoptosis as a determinant of tumor sensitivity to topotecan in human ovarian tumors: preclinical in vitro/in vivo studies Clinical Cancer Research 3 1997 955 961
62. P.A. Ellis I.E. Smith K. McCarthy S. Deter J. Salter M. Dowsett Preoperative chemotherapy induces apoptosis in early breast cancer Lancet 349 1997 849
63. J.A. Roth R.J. Cristiano Gene therapy for cancer: what have we done and where are we going? Journal of the National Cancer Institute 89 1997 21 39
64. J.A. Roth D. Nguyen D.D. Lawrence B.L. Kemp C.H. Carrasco D.Z. Ferson W.K. Hong R. Komaki J.J. Lee J.C. Nesbitt K.M.W. Pisters J.B. Putnam R. Schea D.M. Shin G.L. Walsh M.M. Dolormente C.-I. Han F.D. Martin N. Yen K. Xu L.C. Stephens T.J. McDonnell T. Mukhopadhyay D. Cai Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer Nature Medicine 2 1996 985 991
65. L.B. Owen-Schaub W. Zhang J.C. Cusack L.S. Angelo S.M. Santee T. Fujiwara J.A. Roth A.B. Deisseroth W.W. Zhang E. Kruzel R. Radinsky Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression Molecular and Cellular Biology 15 1995 3032 3040
66. s gene therapy induces apoptosis of human mammary tumors in nude mice Cancer Research 56 1996 1965 1969
67. W.W. Zhang Antisense oncogene and tumor suppressor gene therapy of cancer Journal of Molecular Medicine 74 1996 191 204
68. I. Gibson Antisense to gene therapy of cancer — Recnac Cancer Metastasis Reviews 15 1996 287 299
69. A. Webb D. Cunningham F. Cotter P.A. Clarke F. de Stefano P. Ross M. Corbo Z. Dziewanowska BCL-2 antisense therapy in patients with non-Hodgkins Lymphoma Lancet 349 1997 1137 1141